Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these

 

And in early November, Pfizer released preliminary results for its antiviral pill, Paxlovid, another potentially promising tool for COVID-19 treatment. On Nov. 16, Pfizer formally requested emergency use authorization of the oral pill from the FDA.

Comments